The pharmacologic management of cryptorchidism is:

Rationale: A. Surgical management (orchiopexy) is the standard treatment for cryptorchidism, but pharmacologic therapy can be considered in certain cases. B. Low-dose testosterone is sometimes used to stimulate testicular descent, but its effectiveness is less established than HCG. C. Human chorionic gonadotropin (HCG) can be used to induce testicular descent in some cases of cryptorchidism, particularly when the testes are palpable in the inguinal canal. HCG stimulates Leydig cells to produce testosterone, promoting testicular descent. D. Somatotropin (growth hormone) has no role in the management of cryptorchidism.